23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million ()

logo
TheNewYorkTimes Business
· 5 hours ago
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

banner

Continue reading